Windtree Therapeutics Inc (WINT)

Windtree Therapeutics Inc (WINT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $33,708; returns 1 day +33.3%, 1 year -99.7%.

Windtree Therapeutics, Inc. is a biotechnology company that is shifting its strategy to become a revenue-generating entity while continuing to develop its therapeutic pipeline. Historically focused on therapies for acute cardiovascular diseases and critical conditions, Windtree's lead product candidate is istaroxime, a Phase 2 candidate for acute heart failure and cardiogenic shock.

Groups WINT belongs to

• Biotechnology
• Pharmaceuticals
• Cardiovascular Therapies
• Clinical Stage Biotech
• Strategic Pivot

WINT financial model: income statement, cash flow and balance sheet